Brief: Enzon Pharmaceuticals names Andrew Rackear as CEO

Viskase Holdings

21/03/2016 20:17

March 21 (Reuters) - Enzon Pharmaceuticals Inc  ENZN.O  
    * Appointed Andrew Rackear as chief executive officer and 
secretary of company effective March 31, 2016 
    * Resignation of GEORGE HEBARD III as interim principal 
executive officer, interim chief operating officer and secretary 
 
Source text for Eikon: (1.usa.gov/1WDxoIK) 
Further company coverage:  ENZN.O  
 
 (Bengaluru Newsroom: +1-646-223-8780)